Oesophageal cancer : NICE USC guidance summary

The National Institute for Health and Care Excellence (NICE) provides comprehensive guidance on the management of oesophageal cancer, a critical resource for healthcare professionals involved in the diagnosis, treatment, and care of patients with this condition. Oesophageal cancer, characterized by cancerous growths in the oesophagus, presents significant challenges due to its often late presentation and complex treatment requirements. The NICE guidance on oesophageal cancer meticulously outlines evidence-based recommendations covering the entire patient journey—from initial suspicion based on symptoms and risk factors, through diagnostic procedures, to treatment options and follow-up care.

Key aspects of the guidance include criteria for urgent referrals, indications for diagnostic tests such as upper gastrointestinal endoscopy, and considerations for treatment modalities that range from surgical intervention to chemotherapy and palliative care. Special emphasis is placed on the importance of a multidisciplinary approach, ensuring that patients benefit from the expertise of a comprehensive team including oncologists, surgeons, gastroenterologists, radiologists, and specialist nurses, among others.